Does SARILUMAB Cause Injection site swelling? 547 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 547 reports of Injection site swelling have been filed in association with SARILUMAB (KEVZARA). This represents 2.6% of all adverse event reports for SARILUMAB.
547
Reports of Injection site swelling with SARILUMAB
2.6%
of all SARILUMAB reports
0
Deaths
19
Hospitalizations
How Dangerous Is Injection site swelling From SARILUMAB?
Of the 547 reports, 19 (3.5%) required hospitalization.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SARILUMAB. However, 547 reports have been filed with the FAERS database.
What Other Side Effects Does SARILUMAB Cause?
Drug ineffective (5,065)
Pain (4,833)
Arthralgia (4,139)
Rheumatoid arthritis (3,963)
Joint swelling (3,951)
Condition aggravated (3,247)
Fatigue (3,000)
Rash (2,912)
Alopecia (2,660)
Abdominal discomfort (2,600)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which SARILUMAB Alternatives Have Lower Injection site swelling Risk?
SARILUMAB vs SATRALIZUMAB
SARILUMAB vs SATRALIZUMAB-MWGE
SARILUMAB vs SAXAGLIPTIN
SARILUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SARILUMAB vs SCOPOLAMINE